Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis

Acta Neurologica Scandinavica

Volumn 102, Issue 1, 2000, Pages 31-36

  Stolz, Erwin ^a   Kemkes Matthes, B ^a   Potzsch B ^b   Hahn, M ^a   Kraus, J ^a   Wirbartz, A ^a   Kaps, M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

Author keywords

Cerebral venous thrombosis; Dural sinuses; Intracranial veins; Leiden mutation; Pro thrombin polymorphism; Protein C deficiency; Protein S deficiency

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN VEIN; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; INFANT; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; AGED; BLOOD COAGULATION DISORDERS; CEREBRAL VEINS; CHILD, PRESCHOOL; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN C; PROTEIN S; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0034093930     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102001031.x     Document Type: Article

References (35)

1. 1. BOUSSER MG, CHIRAS J, BORIES J, CASTAIGNE P. Cerebral venous thrombosis - a review of 38 cases. Stroke 1985;16:199-213.
2. 2. AMERI A, BOUSSER MG. Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
3. 3. DE BRUIJN SFTM, STAM J, KOOPMAN MMW, VANDENBROUCKE JP for the Cerebral Venous Sinus Thrombosis Study Group. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. BMJ 1998;316:589-92.
4. 4. MARTINELLI I, SACCHI E, LANDI G, TAIOLI E, DUCA F, MANNUCCI PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7.
5. 5. DESCHIENS MA, CONRAD J, HORELLOU MH et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-30.
6. 6. REUNER KH, RUF A, GRAU A et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998;29:1765-9.
7. 7. DAHLBäCK B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1995;77:1-43.
8. 8. AMBRUSO DR, JACOBSON CJ, HATHAWAY WE. Inherited antithrombin III deficiency in a child. Pediatrics 1980;65:125-31.
9. 9. MAYER K, HARTMANN H, IMMEL A, SEITZ R, EGBRING R. Congenital heterozygote hypoplasminogenemia as a risk factor for thrombosis. Fibrinolysis 1988;2(Suppl. 2):37-8.
10. 10. DE MAAT MPM, KLUFT C, JESPERSEN J, GRAM J. World distribution of factor V Leiden mutation. Lancet 1996;i:347:58.
11. 11. ROSENDAAL FR, DOGGEN CJ, ZIVELIN A et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
12. 12. MILLAR SA, DYKES DD, POLESKY HF. A simple salting out procedure for extracting DNA from nucleated cell. Nucleic Acids Res 1988;16:1215-17.
13. 13. BERTINA RM, KOELEMAN BP, KOSTER T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
14. 14. STIER C, PÖTZSCH B, MÜLLER-BERGHAUS G, SOERGEL M, KLAUS G. Severe thrombophilia in a pediatric patient with end-stage renal disease: detection of the prothrombin gene G20210A mutation. Nephrol Dial Transplant 1998;13:2130-2.
15. 15. YAMAMOTO K, MATSUSHITA T, SUGIURA I et al. Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C. J Lab Clin Med 1992;119:682-9.
16. 16. SIMMONDS RE, ZÖLLER B, IRELAND H et al. Genetic and phenotypic analysis of a large protein S-deficient kindred provides an explanation for the familial coexistence of type I and type II plasma phenotypes. Blood 1997;89:4364-70.
17. 17. SCHRODER W, KOESSLING M, WULFF K, WEHNERT M, HERMANN FH. World distribution of factor V Leiden mutation. Lancet 1996;347:58-9.
18. 18. UTTENREUTHER-FISCHER MM, VETTER B, HELLMANN C et al. Paediatric thrombembolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997;156:277-81.
19. 19. LANE DA, MANNUCCI PM, BAUER KA et al. Inherited Thrombophilia: Part 1. Thromb Haemostas 1996;76:651-62.
20. 20. GURR E, KLOSF G. Thrombembolische Erkrankungen und hereditäre Thrombophilie. DG Klinische Chemie Mitteilungen 1997;28:51-68.
21. 21. WEIH M, VETTER B, ZIEMER S et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol 1998;245:149-52.
22. 22. FAIONI EM, FRANCHI F, ASTI D, SACCHI E, BERNARDI F, MANUCCI PM. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993;70:1067-71.
23. 23. POORT SR, ROSENDAAL FR, REITSMA PH, BERTINA RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
24. 24. BIOUSSE V, CONRAD J, BROUZES C, HORELLOU MH, AMERI A, BOUSSER MG. Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998;29:1398-400.
25. 25. MILETICH J, SMERMAN L, BROZE G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317:991-6.
26. 26. DAIF A, AWADA A, AL-RAJEH S et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 1995;26:1193-5.
27. 27. BARTHELS M, POLIWODA H. Gerinnungsanalysen. 5th ed. Stuttgart, New York: Georg Thieme Verlag, 1997.
28. 28. MARTINELLI I, ROSENDAAL FR, VANDENBROUCKE JP, MANNUCI PM. Oral contraceptives are a risk factor for cerebral vein thrombosis. Thromb Haemost 1996;76:477-8.
29. 29. KAPLAN JM, BILLER J, ADAMS HP. Outcome in non septic spontaneous superior sagittal sinus thrombosis in adults. Cereb Vasc Dis 1991;1:231-4.
30. 30. VILLRINGER A, BOUSSER MG, EINHĀUPL KM. Cerebral venous thrombosis In: HACKE W, ed. Neurocritical Care. Berlin: Springer, 1994;654-60.
31. 31. EINHÄUPL KM, VILLRINGER A, MEISTER W et al. Heparin treatment of sinus venous thrombosis. Lancet 1991;333:597-600.
32. 32. NOETZEL H, JERUSALEM F. Die Hirnvenen-und Sinusthrombosen. Berlin and Heidelberg: Springer, 1965:1-63.
33. 33. SCHULMAN S, RHEDIN AS, LINDMARKER P, CARLSSON A, LATORS G, NICOL P. A comparison of six weeks with six months of oral anticoagulation after a first episode of venous thrombembolism. N Engl J Med 1995;332:1661-5.
34. 34. LEVINE MN, HIRSH J, GENT M. Optimal duration of oral anticoagulant therapy: a randomised trial comparing four weeks with three months of warfarin in patients with proximal deep venous thrombosis. Thromb Haemost 1995;74:606-11.
35. 35. LANE DA, MANNUCCI PM, BAUER KA et al. Inherited thrombophilia: part 2. Thromb Haemost 1996;76:824-34.